{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T17:29:37Z","timestamp":1767374977243,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.tox.2016.07.021","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T17:20:05Z","timestamp":1469726405000},"page":"9-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Inhibition of PAR-4 and P2Y12 receptor-mediated platelet activation produces distinct hepatic pathologies in experimental xenobiotic-induced cholestatic liver disease"],"prefix":"10.1016","volume":"365","author":[{"given":"Nikita","family":"Joshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna K.","family":"Kopec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica L.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James P.","family":"Luyendyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2016.07.021_bib0005","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jhep.2008.03.009","article-title":"Thrombocytopenia associated with chronic liver disease","volume":"48","author":"Afdhal","year":"2008","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tox.2016.07.021_bib0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1006\/taap.1994.1245","article-title":"Platelets and alpha-naphthylisothiocyanate-induced liver injury","volume":"129","author":"Bailie","year":"1994","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2016.07.021_bib0015","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1182\/blood.V60.5.1231.1231","article-title":"Thrombin-induced secretion of serotonin from platelets can occur in seconds","volume":"60","author":"Gear","year":"1982","journal-title":"Blood"},{"key":"10.1016\/j.tox.2016.07.021_bib0020","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/j.1365-2036.2006.02889.x","article-title":"Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options","volume":"23","author":"Giannini","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.tox.2016.07.021_bib0025","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1053\/jhep.2003.50341","article-title":"Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice","volume":"38","author":"Gujral","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.tox.2016.07.021_bib0030","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1538-7836.2004.00783.x","article-title":"Impaired hemostasis and protection against thrombosis in protease-activated receptor 4-deficient mice is due to lack of thrombin signaling in platelets","volume":"2","author":"Hamilton","year":"2004","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.tox.2016.07.021_bib0035","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/202765a0","article-title":"Role of adenosine diphosphate in the aggregation of human blood-platelets by thrombin and by fatty acids","volume":"202","author":"Haslam","year":"1964","journal-title":"Nature"},{"key":"10.1016\/j.tox.2016.07.021_bib0040","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1124\/jpet.113.210880","article-title":"The antifibrinolytic drug tranexamic acid reduces liver injury and fibrosis in a mouse model of chronic bile duct injury","volume":"349","author":"Joshi","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2016.07.021_bib0045","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/jth.12770","article-title":"Coagulation-driven platelet activation reduces cholestatic liver injury and fibrosis in mice","volume":"13","author":"Joshi","year":"2015","journal-title":"J. Thromb. Haemost. JTH"},{"key":"10.1016\/j.tox.2016.07.021_bib0050","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1182\/blood-2015-09-670703","article-title":"Fibrin deposition following bile duct injury limits fibrosis through an alphaMbeta2-dependent mechanism","volume":"127","author":"Joshi","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.tox.2016.07.021_bib0055","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/29325","article-title":"A dual thrombin receptor system for platelet activation","volume":"394","author":"Kahn","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.tox.2016.07.021_bib0060","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1172\/JCI6042","article-title":"Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin","volume":"103","author":"Kahn","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tox.2016.07.021_bib0065","first-page":"707","article-title":"Mechanisms of platelet shape change, aggregation, and release induced by collagen, thrombin, or A23,187","volume":"90","author":"Kinlough-Rathbone","year":"1977","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.tox.2016.07.021_bib0070","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1053\/j.gastro.2010.02.054","article-title":"Thrombocytopenia exacerbates cholestasis-induced liver fibrosis in mice","volume":"138","author":"Kodama","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tox.2016.07.021_bib0075","doi-asserted-by":"crossref","DOI":"10.1111\/jth.13327","article-title":"Role of hemostatic factors in hepatic injury and disease: animal models de-liver","author":"Kopec","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.tox.2016.07.021_bib0080","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nm1780","article-title":"Aggravation of viral hepatitis by platelet-derived serotonin","volume":"14","author":"Lang","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.tox.2016.07.021_bib0085","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/sj.bjp.0707578","article-title":"Platelet-dependent accumulation of leukocytes in sinusoids mediates hepatocellular damage in bile duct ligation-induced cholestasis","volume":"153","author":"Laschke","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tox.2016.07.021_bib0090","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/jth.12783","article-title":"Platelets and fibrin in progression of liver disease: friends or foes","volume":"13","author":"Lisman","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.tox.2016.07.021_bib0095","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1124\/jpet.103.059873","article-title":"Effects of SanOrg123781A, a synthetic hexadecasaccharide, in a mouse model of electrically induced carotid artery injury: synergism with the antiplatelet agent clopidogrel","volume":"309","author":"Lorrain","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2016.07.021_bib0100","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/SLA.0b013e31818584c7","article-title":"Single administration of thrombopoietin prevents progression of liver fibrosis and promotes liver regeneration after partial hepatectomy in cirrhotic rats","volume":"248","author":"Murata","year":"2008","journal-title":"Ann. Surg."},{"key":"10.1016\/j.tox.2016.07.021_bib0105","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.2741\/1939","article-title":"The role of ADP receptors in platelet function","volume":"11","author":"Murugappa","year":"2006","journal-title":"Front. Biosci."},{"key":"10.1016\/j.tox.2016.07.021_bib0110","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1182\/blood.V94.2.684","article-title":"Acute systemic reaction and lung alterations induced by an antiplatelet integrin gpIIb\/IIIa antibody in mice","volume":"94","author":"Nieswandt","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.tox.2016.07.021_bib0115","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1182\/blood.V96.7.2520","article-title":"Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice","volume":"96","author":"Nieswandt","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.tox.2016.07.021_bib0120","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1152\/ajplegacy.1973.225.1.38","article-title":"Platelet aggregation and release: effects of low concentrations of thrombin or collagen","volume":"225","author":"Packham","year":"1973","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.tox.2016.07.021_bib0125","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/j.gastro.2008.04.009","article-title":"Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression","volume":"135","author":"Patsenker","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tox.2016.07.021_bib0130","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jhep.2007.11.021","article-title":"Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies","volume":"48","author":"Popov","year":"2008","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tox.2016.07.021_bib0135","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S1386-6346(02)00247-4","article-title":"Infiltrating neutrophils in bile duct-ligated livers do not promote hepatic fibrosis","volume":"25","author":"Saito","year":"2003","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.tox.2016.07.021_bib0140","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/35092573","article-title":"Role of thrombin signalling in platelets in haemostasis and thrombosis","volume":"413","author":"Sambrano","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.tox.2016.07.021_bib0145","doi-asserted-by":"crossref","first-page":"11069","DOI":"10.1073\/pnas.0510446103","article-title":"The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts","volume":"103","author":"Savi","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tox.2016.07.021_bib0150","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1152\/physrev.1989.69.1.58","article-title":"Molecular mechanisms of platelet activation","volume":"69","author":"Siess","year":"1989","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tox.2016.07.021_bib0155","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-3-642-29423-5_3","article-title":"Platelet signaling","author":"Stalker","year":"2012","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.tox.2016.07.021_bib0160","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/toxsci\/kfq042","article-title":"Protective and damaging effects of platelets in acute cholestatic liver injury revealed by depletion and inhibition strategies","volume":"115","author":"Sullivan","year":"2010","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2016.07.021_bib0165","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.2353\/ajpath.2010.100425","article-title":"The coagulation system contributes to alphaVbeta6 integrin expression and liver fibrosis induced by cholestasis","volume":"177","author":"Sullivan","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tox.2016.07.021_bib0170","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/0092-8674(91)90261-V","article-title":"Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation","volume":"64","author":"Vu","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.tox.2016.07.021_bib0175","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1086\/423384","article-title":"Strong association of hepatitis C virus (HCV) infection and thrombocytopenia: implications from a survey of a community with hyperendemic HCV infection","volume":"39","author":"Wang","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.tox.2016.07.021_bib0180","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/hep.21849","article-title":"Role of alphavbeta6 integrin in acute biliary fibrosis","volume":"46","author":"Wang","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.tox.2016.07.021_bib0185","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1440-1746.2008.05497.x","article-title":"Platelets contribute to the reduction of liver fibrosis in mice","volume":"24","author":"Watanabe","year":"2009","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tox.2016.07.021_bib0190","doi-asserted-by":"crossref","first-page":"G734","DOI":"10.1152\/ajpgi.00300.2003","article-title":"Limited role for CXC chemokines in the pathogenesis of alpha-naphthylisothiocyanate-induced liver injury","volume":"287","author":"Xu","year":"2004","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.tox.2016.07.021_bib0195","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1053\/j.gastro.2014.08.038","article-title":"Extrahepatic platelet-derived growth factor-beta, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice","volume":"147","author":"Yoshida","year":"2014","journal-title":"Gastroenterology"}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X16301561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X16301561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:33:28Z","timestamp":1759534408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X16301561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":39,"alternative-id":["S0300483X16301561"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2016.07.021","relation":{},"ISSN":["0300-483X"],"issn-type":[{"type":"print","value":"0300-483X"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of PAR-4 and P2Y12 receptor-mediated platelet activation produces distinct hepatic pathologies in experimental xenobiotic-induced cholestatic liver disease","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2016.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}